Additional Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Miami VA Health System
    Miami FL. 33125
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Premier Pulmonary Critical Care and Sleep Medicine
    Denison TX. 75020
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Northwestern Medicine
    Chicago IL. 60611
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    University of Rochester
    Rochester NY. 14642
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    University of Louisville
    Louisville KY. 40202
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Beaumont Hospital, Royal Oak
    Royal Oak MI. 48073
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Indiana University Health
    Indianapolis IN. 46202
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Icahn School of Medicine at Mount Sinai
    New York NY. 10029
    View Details

  • Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

    UCLA Health Burbank Specialty Care
    Burbank CA. 91505
    View Details

  • Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

    UCLA
    Los Angeles CA. 90024
    View Details

  • MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    Dynamic Drug Advancement
    Ajax L1S 2J5
    View Details

  • MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    Centre de Recherche Clinique - CHUS
    Sherbrooke QC. J1H 5N4
    View Details

  • 129Xe MRI Cardiopulmonary

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Georgetown University Hospital
    Washington D.C. DC. 20007
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Montefiore Medical Center
    The Bronx NY. 10467
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Washington University School of Medicine
    St Louis MO. 63110
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Paradigm Clinical Research
    Redding CA. 45227
    View Details